TSCQ study: a randomized, controlled, open-label trial of daily trimethoprim-sulfamethoxazole or weekly chloroquine among adults on antiretroviral therapy in Malawi: study protocol for a randomized controlled trial

BACKGROUND: Before antiretroviral therapy (ART) became widely available in sub-Saharan Africa, several studies demonstrated that daily trimethoprim-sulfamethoxazole (TS) prophylaxis reduced morbidity and mortality among HIV-infected adults. As a result, the World Health Organization (WHO) recommende...

Descripción completa

Detalles Bibliográficos
Autores principales: Laurens, Matthew B., Mungwira, Randy G., Nyirenda, Osward M., Divala, Titus H., Kanjala, Maxwell, Muwalo, Francis, Mkandawire, Felix A., Tsirizani, Lufina, Nyangulu, Wongani, Mwinjiwa, Edson, Taylor, Terrie E., Mallewa, Jane, Blackwelder, William C., Plowe, Christopher V., Laufer, Miriam K., van Oosterhout, Joep J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4950772/
https://www.ncbi.nlm.nih.gov/pubmed/27431995
http://dx.doi.org/10.1186/s13063-016-1392-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4950772/
https://www.ncbi.nlm.nih.gov/pubmed/27431995
http://dx.doi.org/10.1186/s13063-016-1392-3

Ejemplares similares